The University of Florida Health Cancer Center is pleased to announce that Steven Madore, Ph.D., has been appointed the center’s associate director for core technologies. In this role, Dr. Madore will be responsible for ensuring the efficient integration of core technologies into all three UFHCC research…
An overarching goal of this line of research is to reduce the burden of pancreatic malignancy.
Dr. Markham will be responsible for advancing the mission of the UFHCC to provide excellence in cancer care as well as facilitating the incorporation of clinical research into clinical oncology practice...
Video series highlights Dr. Bungert’s leukemia research.
We spoke with Christina Cline, R.N., recently to her to learn about what the role entails — including some of its most rewarding and and challenging aspects.
In this role, Dr. Shenkman will be responsible for overseeing the center-wide effort to reduce cancer-related disparities and burden through research in clinical and community settings that addresses prevention, treatment and survivorship.
A study suggests that certain types of immune cells found in cancer — myeloid-derived suppressor cells, or MDSCs — are also present in certain patients diagnosed with severe sepsis and septic shock.
The University of Florida Health Cancer Center is pleased to announce that Alison M. Ivey, R.N., has been appointed associate director of clinical trials for the center’s clinical trials office.
Gwen Creel and Barb Wills stopped by the UFHCC to present a check from the Pink Pumpkin Pedal-Off.
The University of Florida Health Cancer Center is pleased to announce that Dietmar Siemann, Ph.D., has been appointed the center's associate director for cancer education and research career enhancement.